TickerFactsScreenerDevelopers

Akebia Therapeutics, Inc. (AKBA) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $5.01M2012: $1.64M2013: $21.21M2014: $32.78M2015: $49.78M2016: $187.34M2017: $70.16M2018: $104.64M2019: $147.45M2020: $228.70M2021: $149.80M2022: $90.47M2023: $42.92M2024: $51.87M2025: $184.84M$184.84M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$184.84M+256.4%
2024$51.87M+20.8%
2023$42.92M-52.6%
2022$90.47M-39.6%
2021$149.80M-34.5%
2020$228.70M+55.1%
2019$147.45M+40.9%
2018$104.64M+49.2%
2017$70.16M-62.6%
2016$187.34M+276.3%
2015$49.78M+51.9%
2014$32.78M+54.5%
2013$21.21M+1192.8%
2012$1.64M-67.3%
2011$5.01M—